Liaoning Heshi Ophthalmic Hospital Group Co., Ltd
Online roadshow announcement of initial public offering and listing on GEM
Sponsor (lead underwriter): Central China Securities Co.Ltd(601375)
The application of Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. (hereinafter referred to as "the issuer") for the initial public offering of RMB common shares (A shares) (hereinafter referred to as "this offering") has been examined and approved by the GEM Listing Committee of Shenzhen Stock Exchange (hereinafter referred to as "Shenzhen Stock Exchange"), It has been approved to register by China Securities Regulatory Commission (hereinafter referred to as "CSRC") (zjxk [2022] No. 126). This issuance adopts directional placement to strategic investors (hereinafter referred to as "strategic placement") (if any) Offline inquiry placement to qualified investors (hereinafter referred to as "offline issuance") and online pricing issuance to social public investors holding non restricted A-Shares and non restricted depositary receipts in Shenzhen market (hereinafter referred to as "online issuance").
The issuer and the sponsor (lead underwriter) Central China Securities Co.Ltd(601375) (hereinafter referred to as the "sponsor (lead underwriter)") will directly determine the issuance price through offline preliminary inquiry, and offline cumulative bidding inquiry will not be conducted.
This offering does not arrange the strategic placement to the asset management plan of the issuer's senior managers and core employees and other external investors. For example, the offering price exceeds the median and weighted average of the quotation of offline investors after excluding the highest quotation, and the securities investment fund established through public offering after excluding the highest quotation (hereinafter referred to as "public fund") National Social Security Fund (hereinafter referred to as "social security fund"), basic endowment insurance fund (hereinafter referred to as "pension") According to the measures for the administration of enterprise annuity funds (hereinafter referred to as the "measures for the administration of enterprise annuity funds"), the average number of participating insurance funds (hereinafter referred to as the "measures for the administration of enterprise annuity funds") shall be allocated in accordance with the provisions of the measures for the administration of enterprise annuity funds, The issuer and the recommendation institution (lead underwriter) will disclose the total amount of shares allotted to the relevant subsidiaries of the recommendation institution participating in the placement, the number of subscriptions, and Information such as the proportion in the number of shares issued this time and the holding period.
The public offering of 30.5 million new shares accounts for 25.09% of the total share capital after the issuance. All the issuance is new shares, and the shareholders of the company do not offer shares publicly. The total share capital after this public offering is 121558824 shares.
Among them, Initial strategic placement (if the issue price exceeds the lower of the median and weighted average of offline investors' quotations after excluding the highest quotation and the median and weighted average of public funds, social security funds, pensions, enterprise annuity funds and insurance funds after excluding the highest quotation, the relevant subsidiaries of the sponsor will participate in the strategic placement of the issue in accordance with relevant regulations) The number of shares issued is 1525000, accounting for 5% of the number of shares issued this time. The difference between the final strategic placement and the initial strategic placement is transferred back to offline issuance.
Before the launch of the callback mechanism, the initial number of offline shares issued this time was 20282500, accounting for about 70.00% of the number issued after deducting the initial strategic placement; The initial number of shares issued online was 8.6925 million, accounting for about 30.00% of the number issued after deducting the initial strategic placement. The total quantity of final offline and online issuance is the total quantity of this issuance minus the final strategic placement quantity. The final offline and online issuance quantity will be determined according to the call back situation. The final offline and online issuance quantity and strategic placement (if any) will be clearly confirmed in the announcement on the initial public offering of shares by Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. and the preliminary placement results of offline issuance listed on GEM published on March 14, 2022 (T + 2).
In order to facilitate investors to understand the relevant situation and development prospects of the issuer and the relevant arrangements for the subscription of this issuance, the issuer and the recommendation institution (lead underwriter) will hold an online roadshow on this issuance. Please pay attention to it.
1. Online roadshow time: 14:00-17:00, March 9, 2022 (Wednesday, t-1)
2. Online roadshow website:
Panorama · roadshow world (website: http://rs.p5w.net. ）、
CSI roadshow Center (website: http://www.cs.com.cn./roadshow ）；
3. Participants: key members of the issuer's management and relevant personnel of the sponsor (lead underwriter). The full text of the prospectus and relevant materials of this offering can be found on the websites designated by the CSRC (cninfo, www.cn. Info. Com. CN; CSI, www.cs. Com. CN; China Securities, www.cn. Stock. Com; securities times, www.stcn. Com; Securities Daily, www.zqrb. CN; economic reference, www.jjckb. CN) Query.
Please pay attention to it.
Issuer: sponsor (lead underwriter) of Liaoning Heshi Ophthalmic Hospital Group Co., Ltd.: Central China Securities Co.Ltd(601375) March 8, 2022 (no text on this page, online roadshow announcement of Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. on initial public offering and listing on GEM) Seal page)
Issuer: Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. on [], 2022 (there is no text on this page, which is the seal page of the online roadshow announcement of Liaoning Heshi Ophthalmic Hospital Group Co., Ltd. on initial public offering and listing on GEM)
Sponsor (lead underwriter): Central China Securities Co.Ltd(601375) mm / DD / 2022
